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TO THE EDITOR
Stem cell factor (SCF) is the ligand for
the KIT tyrosine kinase and is expressed
by keratinocytes in human interfollicu-
lar epidermis where it exists predomi-
nantly as a transmembrane protein with
an extracellular receptor-binding do-
main (Longley et al., 1993). SCF can
also be produced as a soluble bioactive
molecule by alternate mRNA splicing
or by solubilization of the membrane-
bound form by protease cleavage at one
of several extracellular juxtamembrane
sites (Anderson et al., 1990; Longley
et al., 1997). In human skin, KIT is
expressed by epidermal melanocytes,
and activation of KIT by keratinocyte-
derived SCF is necessary and sufficient
for epidermal melanocyte survival (Ku-
nisada et al., 1998). By contrast, SCF is
not normally expressed postnatally by
epidermal keratinocytes in mice, a fact
that explains why murine interfollicular
epidermis lacks significant numbers of
melanocytes at most anatomic sites and
why murine epidermis is clear (pink or
white), even in ‘‘black’’ mice (Yoshida
et al., 1996). Expression of transgenic
SCF in murine basilar keratinocytes
causes postnatal persistence of interfol-
licular epidermal melanocytes and de-
position of melanin that mimics human
epidermis; and mice with skin that is
‘‘humanized’’ in this manner may be
useful for studying photobiology and
photocarcinogenesis and for studying
melanocyte biology, including normal
and aberrant pigmentation and
the development of melanoma (B.J.
Longley, unpublished studies; D’Orazio
et al., 2006). However, to our knowl-
edge, there is no published work
addressing the potential contribution
of epidermal keratinocyte SCF to cuta-
neous inflammatory or immune
responses that could further affect these
processes.
We have investigated the role of
keratinocyte SCF in irritant and allergic
contact dermatitis using three strains
of mice bearing different copy numbers
of a transgene that expresses predomi-
nantly membrane-bound epidermal
SCF that can be solubilized by cleavage
by enzymes such as chymase (K14-SCF
transgenics, TG1; Longley et al., 1997;
Kunisada et al., 1998). The mice were
designated as 1 , 4 , and 10 ,
corresponding to the relative copy
number. (All procedures were approved
by the Institutional Animal Care and
Use Committees of Columbia Univer-
sity and the University of Wisconsin-
Madison. Please see Supplementary
Materials online for a more detailed
description of the mice, reagents, and
techniques.)
Compared to non-transgenic litter-
mates, SCF-transgenic mice showed
significantly greater ear swelling after
the application of croton oil, a contact
irritant (Figure 1). The intensity of the
ear swelling response increased in
proportion to the level of expression of
the transgene and could be partially
blocked by SU9529, a specific inhibitor
of KIT (Ma et al., 2002) (KIT suppression
data not shown). It should be noted that
the reaction of the 10 mice, expres-
sing the highest levels of SCF, was so
vigorous that some of the animals
developed ulceration, which may have
caused underestimation of their ear
swelling response.
The SCF-transgenic mice also
showed an increased antigen-specific
allergic response to dinitrofluoroben-
zene (Figure 2). The response was
associated with increased antigen-specific
proliferation of lymph node cells
(described in Supplementary Materials)
and was transferable; draining lymph
node cells from sensitized SCF-transgenic
mice caused more than fourfold greater
swelling 24hours after transfer to nu/nu
mice than did draining lymph node cells
from sensitized wild-type mice. Therefore,
antigen-specific draining lymph node cells
appear to contribute to the greater allergic
response observed in SCF-transgenic mice
in vivo.
The fact that increased ear swelling
occurred in several different transgenic
lines and was positively associated with
the transgenic ‘‘gene dosage’’ is evi-
dence that this phenomenon is due to
the targeted effect of epidermal keratino-
cyte SCF expression rather than to a
random insertional event. In addition,
we found that the heightened inflam-
matory response of the transgenic mice
was not associated with an increase in
dermal mast cell density (Table S1),
indicating that SCF acts in the early
phases of contact dermatitis through a
mechanism independent of its role as a
mast cell mitogen.
How might keratinocyte SCF affect
cutaneous inflammation, especially al-
lergic responses mediated by lympho-
cytes that do not express KIT? It is quite
likely that mast cells, which express KIT
and are known to contribute to both
irritant and allergic contact reactions
(Galli and Kitamura, 1987; Kerdel et al.,
1987), are key intermediaries. An heuris-
tic hypothesis is that the initial activa-
tion of resident dermal mast cells
triggered by exposure to an irritant or
allergic contactant causes the release of
chymase or other enzymes, which in
turn cause solubilization of membrane-
bound keratinocyte SCF by cleavage at
one of several extracellular juxtamem-
brane sites (Longley et al., 1997). The
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Abbreviation: SCF, stem cell factor
acute stimulation of mast cells by SCF is
known to lower the threshold for mast
cell degranulation and cause release of
proinflammatory mediators in response
to both immunologic and non-immu-
nologic stimuli (Columbo et al., 1992;
Nakajima et al., 1992; Wershil et al.,
1992), so we further propose that
release of soluble SCF from epidermal
keratinocytes could result in a positive
feedback loop with still more mast cell
degranulation and keratinocyte SCF
solubilization, as well as recruitment
of other inflammatory cells (Longley
et al., 1997). We also recognize that the
effect could involve gd-T cells or NK
cells, which may also express KIT
(Colucci and Di Santo, 2000; Wang
et al., 2000).
Although the precise mechanisms
involved in this phenomenon remain
to be further elucidated, our findings
demonstrate unequivocally that the
production of SCF by epidermal
keratinocytes may contribute to the
cutaneous inflammatory response,
highlighting another critical difference
between murine and human skin.
Recognition of the contribution of
the SCF–KIT pathway to contact
dermatitis suggests a previously
unreported target for the development
of specific anti-inflammatory agents.
Our findings also suggest that the
relevance of traditional murine experi-
mental models for human contact
dermatitis should be re-evaluated in
light of the fact that SCF is expressed
in abundance by epidermal keratino-
cytes in humans but not in mice.
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Figure 1. Irritant ear swelling response to croton oil. A dose–response relationship was seen between the
level of epidermal SCF expressed by transgenic mice and the magnitude of ear swelling (mean±SE) that
developed in response to croton oil at both 6 and 48 hours after exposure (Po11013 by fixed-effect
ANOVA (analysis of variance)). Swelling was significantly greater in 4 and 10 transgenics than in
WT mice at 6 hours, and greater in each of the transgenic substrains than in WT mice at 48 hours.
*Significantly different from WT at Po0.001; **Significantly different from WT at Po0.000001;
two-sided Mann–Whitney U-test, n¼66 (WT), n¼17 (1 ), n¼ 14 (4 ), n¼ 33 (10 ).
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Figure 2. Allergic ear swelling response to DNFB. Sensitized SCF-transgenic mice exhibit a greater
allergic ear swelling response to challenge with DNFB (dinitrofluorobenzene) than do sensitized control
mice, and the increased response can be transferred by draining lymph node cells. Bars show mean ear
swelling response (±SE) by sensitized WT or 4 SCF-transgenics (direct challenge group), or ear
swelling response in nu/nu mice given lymph node cells from sensitized WT or 4 SCF-transgenic mice
(adoptive transfer group). Measurements in all groups were obtained 24 hours after challenge. Each of
these experiments was performed at least twice with similar results. Direct challenge: *Significantly
different from unsensitized WT or unsensitized transgenic, Po0.01; **Significantly different from all
other direct challenge groups (unsensitized and sensitized WT, and unsensitized transgenic),
Po0.01; two-sided Mann–Whitney U-test, n¼ 6 for each group. Adoptive transfer: **Significantly
different from all other adoptive transfer groups (unsensitized and sensitized WT, and unsensitized
transgenic), Po0.001; two-sided Mann–Whitney U-test, n¼6 for each group.
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Sebocytes Express Functional Cathelicidin Antimicrobial
Peptides and Can Act to Kill Propionibacterium Acnes
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TO THE EDITOR
Cathelicidins comprise an important
family of antimicrobial peptides that
are essential for protection of skin
against bacterial infection in mice
(Nizet et al., 2001), and are relevant
to infection in human skin diseases
such as atopic dermatitis (Ong et al.,
2002). The human cathelicidin gene
(Camp) is expressed as an inactive
precursor protein (hCAP18) and is
present in neutrophils, mast cells,
keratinocytes, and eccrine glands
(Braff et al., 2005). hCAP18 consists of
an N-terminal signal peptide, a cathelin
domain, and a C-terminal region en-
coding the antimicrobial domain
(Sorensen et al., 2001). After proteolytic
processing of hCAP18 to peptides such
as LL-37, the peptide exerts antimicro-
bial activity that protects the host from
infection. In this study we determined if
cathelicidin is produced by sebocytes,
thereby establishing its potential to add
to defense of the skin by this cell.
The sebaceous gland has been
suspected to provide protection to the
external skin surface, but its func-
tions were only recently understood
(Zouboulis, 2003). Lipids produced by
the sebocyte exhibit antibacterial acti-
vity (Georgel et al., 2005) and peptides
of the b-defensin family have been
found in human pilosebaceous units
(Chronnell et al., 2001). Since cathe-
licidin has synergistic activity with
b-defensins, it was of interest to deter-
mine the expression of cathelicidin in
the sebaceous gland.
hCAP18 mRNA was detected by
reverse transcriptase-PCR (RT-PCR)
in isolated human sebaceous glands
microdissected from normal scalp skin
(Figure 1a). Cathelicidin protein was
detected in sebaceous glands in normal
human scalp tissue examined with
anti-LL37 antibody (Murakami et al.,
2002; Figure 1b). Western blot analysis
of extracts from isolated human sebac-
eous glands demonstrated a single
band corresponding to LL-37 (Figure
1c). This finding is in contrast to
cathelicidin isolated from neutrophils,
where the predominant form seen was
the hCAP18 precursor (Sorensen et al.,
2001).
hCAP18 mRNA was also detectable
in SZ95 sebocytes (Zouboulis et al.,
1999) by quantitative real-time RT-PCR,
and was induced by 1,25(OH)2 vitamin
D3 (Figure 1d). The expression of
hCAP18 mRNA was also induced by
Propionibacterium acnes (P. acnes)
culture supernatant (Figure 1e). Cathe-
licidin protein was also detected by
immunofluorescence and this was
enhanced with 1,25(OH)2 vitamin D3
(100 nM) (Figure 1f). The concentrations
of cathelicidin detected by ELISA
were 0.17mg per 106 SZ95 sebocytes
(vehicle control) and 0.39 mg per 106
SZ95 sebocytes (100 nM 1,25(OH)2
vitamin D3) (Figure 1g).
To further define the response of
SZ95 sebocytes to vitamin D, the
expression of the vitamin D-dependent
gene CYP24A1 (24-hydroxylase), and
vitamin D receptor, was examined.
CYP24A1 mRNA was induced 28-fold
by 100 nM of 1,25(OH)2 vitamin D3
(Figure 1h). The vitamin D receptor
was abundantly detected by immuno-
fluorescence (Figure 1i). These results
confirmed that SZ95 cells were vitamin
D responsive.
To more precisely determine the
mass and sequence of the cathelicidin
peptide, SZ95 sebocytes were evalu-
ated by surface-enhanced laser deso-
rption/ionization–time of flight–mass
spectrometry with anti-LL37 antibody
capture. Surface-enhanced laser deso-
rption/ionization–time of flight–mass
spectrometry detected a single peak
with a molecular mass of 4,496-Da
(Figure 1j), identical to the expected
Abbreviations: P. acnes, Propionibacterium acnes; RT-PCR, reverse transcriptase-PCR; S. aureus,
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